News | Quality Assurance (QA) | April 04, 2019

Varian Halcyon Commissioned at MedStar Southern Maryland Hospital Center With IBA's myQA Halo

myQA Halo specifically designed to enable independent commissioning and efficient beam data collection for Varian Halcyon system

Varian Halcyon Commissioned at MedStar Southern Maryland Hospital Center With IBA's myQA Halo

April 4, 2019 — IBA (Ion Beam Applications S.A.) announced the successful commissioning of the Varian Halcyon radiation therapy system at the Radiation Oncology Center at MedStar Southern Maryland Hospital Center, based on an IBA Dosimetry independent beam scanning solution.

IBA has designed myQA Halo, a dedicated solution that allows medical physicists to efficiently and accurately perform all the required scanning for commissioning, acceptance and annual testing of the Halcyon system. The team at MedStar Health has now successfully commissioned their new Halcyon Machine version 2.0 using the myQA Halo solution. The entire commissioning work, including system setup and all measurements, was completed efficiently in one day as confirmation of the gold standard data used in the radiation treatment planning system (RTPS).

The myQA HALO system is specifically designed to enable independent commissioning and efficient beam data collection for the Varian Halcyon system. Key components include the Blue Phantom Compact, a small footprint, lightweight water phantom that addresses weight requirements of the Varian Halcyon couch. The Stealth Reference Chamber, with its dedicated Halcyon holder, supports small field beam scanning accuracy and reproducibility of field sizes down to 0.5 x 0.5 cm2. The myQA Accept scanning software enables beam scanning efficiency that is integrated into the myQA global software platform.

For more information: www.iba-worldwide.com, www.varian.com

Related Content

Proton Therapy Lowers Risk of Side Effects Compared to Conventional Radiation
News | Proton Therapy | May 23, 2019
Cancer patients getting proton therapy instead of traditional photon radiation are at a significantly lower risk of...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
Varian Acquiring Cancer Treatment Services International
News | Radiation Therapy | May 21, 2019
Varian Medical Systems announced it has entered into a definitive agreement to acquire India’s Cancer Treatment...
Videos | Radiation Therapy | May 21, 2019
This is a walk through of the ViewRay MRIdian MRI-guided radiotherapy system installed at ...
Partial Breast Irradiation Effective, Convenient Treatment Option for Low-Risk Breast Cancer
News | Radiation Therapy | May 20, 2019
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast...
New Method Improves Ability to Measure and Maximize Radiation Therapy Dose
News | Radiation Therapy | May 14, 2019
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime....
Sponsored Content | Videos | Radiation Oncology | May 13, 2019
At ASTRO 2018, Accuray showcased new patient-fi
Radiotherapy After Chemo May Improve Survival in Advanced Hodgkin's Lymphoma Patients
News | Radiation Therapy | May 10, 2019
Patients with advanced Hodgkin's lymphoma who have large tumors at the time of diagnosis may benefit from radiotherapy...
IBA Partnering to Develop Advanced Digital Proton Therapy Technologies in Belgium
News | Proton Therapy | May 10, 2019
IBA (Ion Beam Applications SA) announced a research agreement with Skandionkliniken, Université Catholique de Louvain...